Clinical Trial Update: Efficacy of Azithromycin in MSAF Cases to Improve Maternal and Neonatal Outcomes [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating azithromycin for improving maternal and neonatal outcomes in meconium-stained cases; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meconium-stained Amniotic Fluid and Associated Postpartum Complications

Drugs mentioned

• Azithromycin (azithromycin)

Snippet

Sponsor: Cairo University | Conditions: Meconium Stained, Azithromycin | Phase 4 | Status: COMPLETED